Structure Therapeutics Inc. GPCR
- aleniglipron — Obesity Phase 3
- aleniglipron — Type 2 Diabetes Phase 3
GLP-1R (2 companies · 4 programs)
Companies with an active program directed at GLP-1R.
Viking Therapeutics, Inc. VKTX
- VK2735 — Obesity Phase 3
- VK2735 — Obesity Phase 2